| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.4M | — | — |
| Cost of Revenue | $2.3M | — | — |
| R&D Expense | $145K | -71.8% | -65.0% |
| SG&A Expense | $19.6M | +622.7% | +1101.2% |
| Operating Income | -$15.4M | -375.5% | -650.0% |
| Interest Expense | $1.3M | — | +3351.3% |
| Pre-tax Income | -$16.7M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $14.2M | — | — |
| Accounts Receivable | $8.0M | — | — |
| Inventory | $24.1M | — | — |
| Current Assets | $49.8M | +5947.4% | +2225.4% |
| Total Assets | $126.4M | — | +5808.4% |
| Current Liabilities | $24.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$16.3M | — | — |
| Investing Cash Flow | $2.8M | — | — |
| Financing Cash Flow | $27.3M | — | — |
| -885.4% |
| Income Tax | -$465K | — | — |
| Net Income | -$16.2M | -370.8% | -858.2% |
| EPS (Basic) | -$5.30 | +1.5% | -1727.6% |
| EPS (Diluted) | -$5.30 | +1.5% | -80.9% |
| +594.3% |
| Total Liabilities | $68.2M | +831.8% | +1811.2% |
| Stockholders' Equity | $58.3M | +997.0% | +4180.8% |